Amendment Number Five to Non-Exclusive Distribution AgreementExclusive Distribution Agreement • August 6th, 2014 • Dexcom Inc • Surgical & medical instruments & apparatus
This Amendment Number Five to the Non-Exclusive Distribution Agreement (“Amendment Number Five”) is made as of this 14th day of March, 2014, by and between DexCom, Inc., a Delaware corporation, with a principal place of business at 6340 Sequence Drive, San Diego, California 92121 (the "Company") and BYRAM HEALTHCARE and all subsidiaries, a New Jersey corporation with offices located at 120 Bloomingdale Road, Suite 301, White Plains, NJ (the “Distributor”).
SETTLEMENT AND LICENSE AGREEMENTSettlement and License Agreement • August 6th, 2014 • Dexcom Inc • Surgical & medical instruments & apparatus • Delaware
This Settlement and License Agreement (the “Agreement”) is entered into by and between Abbott Diabetes Care Inc., a Delaware corporation having a principal place of business at 1420 Harbor Bay Parkway, Alameda, CA 94502 (“ADC”), and DexCom, Inc., a Delaware corporation having a principal place of business at 6340 Sequence Drive, San Diego, CA 92121 (“DexCom”), each of which is referred to as a “Party” and which are collectively referred to as the “Parties,” as of the date on which the last of the two Parties signs the Agreement (the “Effective Date”).
